SYK vs. EW

In the year-to-date period, SYK achieves a 1.63% return, which is significantly lower than EW's 2.72% return. Over the past 10 years, SYK has outperformed EW with an annualized return of 15.88%, while EW has yielded a comparatively lower 13.42% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SYK Sharpe Ratio is 0.45, which is higher than the EW Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of SYK and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

SYK's dividend yield for the trailing twelve months is around 0.90%, while EW has not paid dividends to shareholders.

The maximum SYK drawdown since its inception was -58.63%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for SYK and EW. For additional features, visit the drawdowns tool.

Stryker Corporation (SYK) has a higher volatility of 12.65% compared to Edwards Lifesciences Corporation (EW) at 11.47%. This indicates that SYK's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Stryker Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.